IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)

INTRODUCTION: Children with diffuse intrinsic pontine glioma (DIPG) have a dismal prognosis. Checkpoint blockade has revolutionized treatment of some resistant cancers. METHODS: Pembrolizumab, a PD-1 inhibitor, was administered to children with progressive DIPG (Stratum A) and results are reported h...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Hwang, Eugene, Onar, Arzu, Young-Poussaint, Tina, Mitchell, Duane, Kilburn, Lindsay, Margol, Ashley, Gilheeny, Stephen, Lin, Tong, Dunkel, Ira, Fouladi, Maryam
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012545/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.325
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki